Meta Platforms, Inc. (META) Insider Transactions

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F8, F14, F10

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F8, F13, F10

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F8, F12, F10

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F8, F11, F10

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F8, F9, F10

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F2, F7, F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F2, F6, F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F2, F5, F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F2, F4, F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F2, F3, F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

F2 The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8 The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15 The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

F16 Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

F17 Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

F18 Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

F19 Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

F20 Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

F21 Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

F22 Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

F23 Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

F24 Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

F25 Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.

F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $700.00 to $700.92 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $725.00 to $725.06 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.

References: F1, F4, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.

F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $700.00 to $700.92 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $725.00 to $725.06 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.

References: F1, F2, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1, F5

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.

F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $675.005 to $675.35 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust.

F4 Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.

References: F1, F2, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025.

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1, F5

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025.

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025.

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025.

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025.

F2 Shares held of record by the reporting person, manager of Olivan D LLC.

F3 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

F4 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

F5 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.

F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $650.00 to $650.93 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $651.015 to $651.26 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.

References: F1, F4, F3